Published in Science Translational Medicine · View the paper (DOI)
A new laboratory test using artificial intelligence tools has been shown to more accurately sort out which people with pancreatic cysts will go on to develop pancreatic cancers. The test, dubbed CompCyst, correctly identified patients who did not need surgery in over half of cases.
Coverage from 2 institutions